EyePoint Pharmaceuticals
EYPT
EYPT
82 hedge funds and large institutions have $368M invested in EyePoint Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 88 → 82 (-6)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
82
Holding in Top 10
1
Calls
$3.39M
Puts
$248K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$4.73M | |
| 3 | +$4.53M | |
| 4 |
Goldman Sachs
New York
|
+$3.03M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.71M |
Top Sellers
| 1 | -$6.32M | |
| 2 | -$2.75M | |
| 3 | -$2.64M | |
| 4 |
Two Sigma Investments
New York
|
-$2.11M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.04M |